Skip to main content
logo
Alaunos Therapeutics, Inc. (TCRT)
NASDAQ: TCRT · Real-Time Price · USD
2.260
+0.050 (2.26%)
At close: Jun 12, 2026, 4:00 PM EDT
2.255
-0.005 (-0.22%)
Pre-market: Jun 15, 2026, 4:26 AM EDT

Alaunos Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
00.010.010.012.920.4
Revenue Growth (YoY)
-70.00%-50.00%100.00%-99.83%634.17%-
Gross Profit
00.010.010.012.920.4
Selling, General & Admin
2.712.874.4612.2213.1427.56
Research & Development
1.441.360.3616.2825.0249.64
Other Operating Expenses
---6.370.130.74
Total Operating Expenses
4.154.234.8234.8738.2977.95
Operating Income
-4.15-4.23-4.81-34.27-35.11-77.55
Interest Expense
----1.92-3.15-1.19
Other Non-Operating Income (Expense)
0.070.10.270.18-2.1-1.22
Total Non-Operating Income (Expense)
0.070.10.27-1.75-5.25-2.4
Pretax Income
-4.11-4.18-4.68-35.14-37.73-78.75
Net Income
-4.11-4.18-4.68-35.14-37.73-78.75
Net Income to Common
-4.11-4.18-4.68-35.14-37.73-78.75
Shares Outstanding (Basic)
222211
Shares Outstanding (Diluted)
222211
Shares Change (YoY)
27.01%21.68%0.11%10.50%1.27%2.27%
EPS (Basic)
-2.13-2.20-2.92-21.97-26.10-55.50
EPS (Diluted)
-2.13-2.20-2.92-21.97-26.10-55.50
Free Cash Flow
-3.13-2.97-4.97-30.34-29.45-64.79
Free Cash Flow Per Share
-1.54-1.52-3.10-18.97-20.34-45.33
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-138167.00%-84500.00%-48120.00%-685340.00%-1201.40%-19484.70%
Profit Margin
-136967.00%-83520.00%-46790.00%-702800.00%-1291.24%-19786.70%
FCF Margin
-104300.00%-59340.00%-49710.00%-606780.00%-1007.80%-16279.10%
EBITDA
-4.13-4.22-4.81-31.95-32.35-74.95
EBITDA Margin
-137667.00%-84360.00%-48100.00%-639040.00%-1106.98%-18832.20%
EBIT
-4.15-4.23-4.81-34.27-35.11-77.55
EBIT Margin
-138167.00%-84500.00%-48120.00%-685340.00%-1201.40%-19484.70%
SEC Filings: 10-K · 10-Q